Literature DB >> 15042513

Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2.

Anren Li1, Xiaodong Jiao, Francis L Munier, Daniel F Schorderet, Wenliang Yao, Fumino Iwata, Mutsuko Hayakawa, Atsushi Kanai, Muh Shy Chen, Richard Alan Lewis, John Heckenlively, Richard G Weleber, Elias I Traboulsi, Qingjiong Zhang, Xueshan Xiao, Muriel Kaiser-Kupfer, Yuri V Sergeev, J Fielding Hejtmancik.   

Abstract

Bietti crystalline corneoretinal dystrophy (BCD) is an autosomal recessive retinal dystrophy characterized by multiple glistening intraretinal crystals scattered over the fundus, a characteristic degeneration of the retina, and sclerosis of the choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. The BCD region of chromosome 4q35.1 was refined to an interval flanked centromerically by D4S2924 by linkage and haplotype analysis; mutations were found in the novel CYP450 family member CYP4V2 in 23 of 25 unrelated patients with BCD tested. The CYP4V2 gene, transcribed from 11 exons spanning 19 kb, is expressed widely. Homology to other CYP450 proteins suggests that CYP4V2 may have a role in fatty acid and steroid metabolism, consistent with biochemical studies of patients with BCD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042513      PMCID: PMC1181977          DOI: 10.1086/383228

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  The metabolism of fatty acids in human Bietti crystalline dystrophy.

Authors:  J Lee; X Jiao; J F Hejtmancik; M Kaiser-Kupfer; W A Gahl; T C Markello; J Guo; G J Chader
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

2.  Bietti's crystalline dystrophy. A clinicopathologic correlative study.

Authors:  D J Wilson; R G Weleber; M L Klein; R B Welch; W R Green
Journal:  Arch Ophthalmol       Date:  1989-02

3.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

4.  Bietti's tapetoretinal degeneration with marginal corneal dystrophy crystalline retinopathy.

Authors:  R B Welch
Journal:  Trans Am Ophthalmol Soc       Date:  1977

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Genetic aspects of retinitis pigmentosa in China.

Authors:  D N Hu
Journal:  Am J Med Genet       Date:  1982-05

7.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

8.  Information analysis of human splice site mutations.

Authors:  P K Rogan; B M Faux; T D Schneider
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

9.  Identification, isolation, and characterization of a 32-kDa fatty acid-binding protein missing from lymphocytes in humans with Bietti crystalline dystrophy (BCD).

Authors:  J Lee; X Jiao; J F Hejtmancik; M Kaiser-Kupfer; G J Chader
Journal:  Mol Genet Metab       Date:  1998-10       Impact factor: 4.797

10.  Bietti's crystalline corneoretinal dystrophy: a cross-sectional study.

Authors:  Asimina Mataftsi; Leonidas Zografos; Elena Millá; Michel Secrétan; Francis L Munier
Journal:  Retina       Date:  2004-06       Impact factor: 4.256

View more
  87 in total

Review 1.  Characterizing proteins of unknown function: orphan cytochrome p450 enzymes as a paradigm.

Authors:  F Peter Guengerich; Zhongmei Tang; S Giovanna Salamanca-Pinzón; Qian Cheng
Journal:  Mol Interv       Date:  2010-06

2.  Bietti crystalline dystrophy and choroidal neovascularisation.

Authors:  B Gupta; S Parvizi; M D Mohamed
Journal:  Int Ophthalmol       Date:  2010-10-23       Impact factor: 2.031

3.  CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.

Authors:  Mariko Nakano; Edward J Kelly; Constanze Wiek; Helmut Hanenberg; Allan E Rettie
Journal:  Mol Pharmacol       Date:  2012-07-06       Impact factor: 4.436

4.  Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy.

Authors:  Geoffrey K Broadhead; Andrew A Chang
Journal:  Korean J Ophthalmol       Date:  2014-03-14

5.  Functional and clinical findings in 3 female siblings with crystalline retinopathy.

Authors:  Hongling Chen; Mingzhi Zhang; Shizhou Huang; Dezheng Wu
Journal:  Doc Ophthalmol       Date:  2007-10-26       Impact factor: 2.379

6.  Bietti's crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics.

Authors:  Audra Mei Yee Fong; Adrian Koh; Kelvin Lee; Chong Lye Ang
Journal:  Int Ophthalmol       Date:  2008-10-15       Impact factor: 2.031

7.  Adaptive optics imaging of the outer retinal tubules in Bietti's crystalline dystrophy.

Authors:  R Battu; M C Akkali; D Bhanushali; P Srinivasan; R Shetty; T T J M Berendschot; J S A G Schouten; C A Webers
Journal:  Eye (Lond)       Date:  2016-02-26       Impact factor: 3.775

8.  Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase.

Authors:  Mariko Nakano; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2009-08-06       Impact factor: 3.922

Review 9.  The use of SD-OCT in the differential diagnosis of dots, spots and other white retinal lesions.

Authors:  Elena Zaharova; Jerome Sherman
Journal:  Eye Brain       Date:  2011-10-25

10.  A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy.

Authors:  Yanping Song; Guoyan Mo; Guohua Yin
Journal:  Int Ophthalmol       Date:  2012-12-14       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.